Tag: Food & Drug Administration
Maker Halts Distribution of Generic Zantac Due to Possible Carcinogen
Preliminary tests revealed low levels of the nitrosamine impurity NDMA in some ranitidine products
FDA Warns Juul About Illegal Marketing Claims, Pitch to Youth
FDA questions claims such as Juul is 'much safer than cigarettes' and the 'FDA would approve it any day'
FDA Reports Rare Cases of Liver Injury, Failure With Hep C Therapies
Worsening liver functioning, liver failure reported among patients contraindicated for HCV therapies
‘Miracle Mineral Solution’ Is No Miracle Cure, FDA Warns
When mixed, the solution develops into a dangerous bleach
FDA: Approval of Zolgensma Was Based on Manipulated Data
Despite inaccurate data, FDA says it is 'confident that Zolgensma should remain on the market'
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib
Increased risk seen with 10 mg dose of tofacitinib used for treating ulcerative colitis
FDA Approves First Noninjection Glucagon Therapy
Baqsimi nasal powder approved for emergency treatment of severe hypoglycemia in patients ≥4 years
Allergan Recalls Textured Breast Implants Linked to Lymphoma
FDA requested recall to protect women from breast implant-associated anaplastic large cell lymphoma
FDA Grants First Approvals for Generic Versions of Lyrica
Generic versions approved for neuropathic pain management, fibromyalgia, partial onset seizures
Recarbrio OK’d for Complicated Urinary Tract, Intra-Abdominal Infections
Drug approved to treat patients with limited or no alternative antibacterial drugs to treat infection
